Physical Exercise During the Cancer Care Pathway (ECOLE)

June 11, 2026 updated by: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Background: Physical exercise is proven safe and effective in improving quality of life and reducing treatment-related side effects in oncology. However, patient adherence to international guidelines remains suboptimal. Investigating the knowledge, attitudes, and practices (KAP) regarding physical activity is crucial to identifying unmet educational needs and barriers.

Objective: This multicenter, cross-sectional observational study (ECOLE project) aims to assess KAP levels concerning exercise among cancer patients and explore the correlations between KAP scores and sociodemographic or clinical variables.

Methods: Over a 6-month period, an anonymous online survey (Microsoft Forms) will be administered to adult cancer patients (≥18 years old) at any disease or treatment stage. A minimum sample size of 370 participants is targeted. Statistical analyses will include Descriptive Statistics, Exploratory and Confirmatory Factor Analyses to validate KAP scales, and Multivariable Logistic Regression to identify predictors of adherence (≥150 minutes/week) and perceived barriers or facilitators.

Expected Results: The study will provide a comprehensive overview of physical activity perceptions and behaviors in oncology. These insights will support the design of targeted educational interventions and structured exercise programs, contributing to the development of a novel "Exercise Oncology Specialist" within supportive care teams.

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

370

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • France
      • Paris, France, 92300
  • Romania
      • Iași, Romania, 700506
        • Universitatea Alexandru Ioa Cuza din Iasi
        • Contact:
        • Principal Investigator:
          • Beatrice Abalasei

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Adult cancer patients (≥18 years old), at any stage of the oncological journey (undergoing treatment, posttreatment, or advanced disease).

Description

Inclusion Criteria:

  • Age ≥18 years
  • Oncological diagnosis
  • Ability to understand the language of the respective country of origin
  • Electronic informed consent

Exclusion Criteria:

- Failure to accept the informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
physical exercise in cancer patients.
Time Frame: 1 day
To evaluate the level of knowledge, attitudes, and practices (KAP) related to physical by administering the study questionnaire.exercise in cancer patients.
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
safety of physical exercise oncology
Time Frame: 1 day
Determine the level of knowledge regarding the benefits and safety of physical exercise by administering the study questionnaire.
1 day
self-efficacy regarding exercise oncology
Time Frame: 1 day
Evaluate attitudes, perceptions, and self-efficacy regarding physical activity by administering the study questionnaire.
1 day
relationship between exercise oncology and oncological journey
Time Frame: 1 day
Analyze the potential relationship between knowledge, attitudes, and the practice of physical exercise
1 day
demographic and clinical variables in exercise oncology
Time Frame: 1 day
Explore the role of demographic and clinical variables (e.g., age, sex, tumor type, phase of treatment) by administering the study questionnaire.
1 day
barriers and facilitators to exercise oncology
Time Frame: 1 day
Identify potential barriers and facilitators to the practice of physical exercise by administering the study questionnaire.
1 day
interest of cancer patients in exercise oncology
Time Frame: 1 day
Assess the interest of cancer patients in structured physical exercise programs by administering the study questionnaire.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Investigators

  • Principal Investigator: Stefano Magno, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 15, 2026

Primary Completion (Estimated)

December 15, 2026

Study Completion (Estimated)

October 30, 2027

Study Registration Dates

First Submitted

June 11, 2026

First Submitted That Met QC Criteria

June 11, 2026

First Posted (Actual)

June 17, 2026

Study Record Updates

Last Update Posted (Actual)

June 17, 2026

Last Update Submitted That Met QC Criteria

June 11, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 27191

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe